Then, we further evaluated the prognostic value of the rest complement genes, whose mRNA expressions were not altered in HCC tissues, including C1S, C2, C3, C5, C8A, C8B, C8G, CFB, CFI, CFH, CFHR1, CFHR2, CFHR4, CFHR5, SERPING1, MASP1, MASP2, MBL2, C5AR2, C4BPA, C4BPB, VTN, CLU, CD59, CPN1, CR2, and ITGAM. This evidence concerns the gene CFI and hepatocellular carcinoma.